China
Africa
Explore chapters and articles related to this topic
Elite Nigerian health care academics in diaspora
Published in Joseph A. Balogun, Health Care Education in Nigeria, 2020
Chukuka is one of the world’s preeminent scientists who first used near-infrared lasers, and monochromatic light to promote collagen polymerization and alignment in animal models of soft tissue injury and for the treatment of chronic ulcers that are unresponsive to antibiotic therapy. His contributions to the science of photo-biomodulation produced significant publications, a patent, journal editorial boards, and academic leadership positions. Chukuka was honored in 2018 with the Lifetime Achievement Award by the North American Association of Photobiomodulation Therapy. He is a fellow of the American Society for Laser Medicine and Surgery and American College of Sports Medicine (James Hope College, 2019).
Routes to gender-affirming surgery
Published in Gabriele Griffin, Malin Jordal, Body, Migration, Re/Constructive Surgeries, 2018
The private hospital is situated in a suburban area of Belgrade, in a building surrounded by several other businesses. If it was not for its name, written with pink letters on the otherwise grey wall, one would not guess from the outside that this is a hospital. It has three floors. The reception hall on the ground floor is mostly white: white floor, white reception desk, white walls, white chairs, but with some pink pillows and other pink details, such as the banister of the stairs to the second floor. A large poster with a picture of a suntanned white woman on a beach in a one-piece swimsuit with a deep V in front is also displayed. The choice of colours and the image match the imaginary of what a private hospital for plastic surgery might look like. This is also one of the main areas of expertise here. In addition to a range of plastic surgeries, the hospital offers urogenital and reconstructive surgery, gynaecological surgery, some general surgeries, vascular surgery and different forms of laser medicine.
Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study
Published in Climacteric, 2022
The neodymium:YAG (Nd:YAG) laser is a solid-state crystal laser-emitting light with a wavelength of 1064 nm that has a deeper optical penetration into tissue. The Nd:YAG laser is one of the most versatile and interesting lasers in dermatological laser medicine, having a wide spectrum of applications. Depending on the wavelength and mode, the Nd:YAG laser can be used for benign pigmented lesions (tattoos, traumatic tattoos, cafe-au-lait macules, lentigines), epilation and vascular lesions (teleangiectasias, hemangiomas). With its long pulses and durations in the range of seconds (PIANO mode), the Nd:YAG laser is ideal for homogeneous bulk heating of the tissues, such as the dermis or the subcutaneous fat. In the PIANO mode, with long pulse duration in the range of seconds, deeper structures can be reached in a very gentle, practically painless way. The PIANO mode has been successfully used for esthetic and dermatological indications, including lichen sclerosus treatment [16,17]. The combination of Er:YAG and Nd:YAG lasers has been demonstrated to be effective for non-invasive dermatologic and esthetic indications [16,18,19]. Therefore, the characteristics of the Nd:YAG laser in the PIANO mode could be of help also in treating the vulva and particularly the posterior commissure in PMW suffering from GSM. The aim of our pilot study was to investigate the efficacy of combined VEL and Nd:YAG laser treatment in PMW suffering from GSM with superficial dyspareunia.
Prospective analysis of the port-wine stain patient population in the Netherlands in light of novel treatment modalities
Published in Journal of Cosmetic and Laser Therapy, 2018
M. Ingmar van Raath, Caroline A. Bambach, Lea M. Dijksman, Albert Wolkerstorfer, Michal Heger
Our data suggests that age is not a factor in seeking the treatment, which adds to the size of the potential market for new treatment modalities. The willingness of patients to travel for a successful PWS treatment could enable the establishment of a number of specialized treatment centres. Moreover, the willingness of individuals to pay more for their PWS-bearing child than for themselves is in harmony with the advice to start treatment at young age. This advice is based on studies that have found increased therapeutic efficacy in children and the possible prevention of PWS-related psychological morbidity (42,49–52). Several novel treatment modalities combine laser therapy with drug-administration (53–55). Hence, clinical introduction of these modalities requires endorsement by laser system producers and the pharmaceutical industry. However, laser system producers have largely left the market for PWS-therapies and/or ceased to invest in PWS therapies (personal communication with laser system provider representatives at the 30th annual meeting of the American Society for Laser Medicine and Surgery, Grapevine, TX, April 2011). Moreover, the limited number of PWS patients puts a strain on the potential return on investment and, thus, lessens the appeal for pharmaceutical companies to develop and/or produce these drugs. Addition of drug administration also increases the costs of a treatment. However, novel treatment modalities that are associated with an improved therapeutic efficacy could decrease the necessary number of treatments and therefore reduce total treatment costs. Unfortunately, the costs of a new PWS treatment is likely not to be covered by health insurance in most countries as PWSs are often (wrongfully) perceived as a purely cosmetic intervention. In this Dutch cohort, patients were prepared to pay a substantial amount of money. However, the costs of treatment might limit (global) implementation of novel treatment modalities where the costs exceed 11% of net annual income.
Accelerated wound healing with a dexpanthenol-containing ointment after fractional ablative CO2 laser resurfacing of photo-damaged skin in a randomized prospective clinical trial
Published in Cutaneous and Ocular Toxicology, 2019
Ruth Heise, Laurenz Schmitt, Laura Huth, Laura Krings, David Kluwig, Krista-Vasiliki Katsoulari, Timm Steiner, Frank Hölzle, Jens Malte Baron, Sebastian Huth
Patients were recruited consecutively on a first-come-first-served basis at a German treatment center for laser surgery (Interdisciplinary Center for Laser Medicine, RWTH Aachen University). Patients eligible for participation were selected according to the following inclusion and exclusion criteria to ensure homogeneity within the study cohort: